Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DX25FVJFC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $17,212
Award facts
- Contract value 100% obligated
- $17,211.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $17,211.96 to AmerisourceBergen Drug Corp for Kisqali 400 mg daily dose tablets (42-count supply) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, a $999.999 billion blanket purchasing vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement and maintains an extensive portfolio of federal contract awards covering diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's federal contracting demonstrates significant capability in fulfilling competitive procurements for both brand-name and generic medications supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Kisqali is an oncology medication, indicating this delivery order supports cancer treatment needs within the military healthcare system.
Quick answers
Who was awarded contract SPE2DX25FVJFC?
SPE2DX25FVJFC was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 22, 2025.
How much is contract SPE2DX25FVJFC worth?
The government has obligated $17,212 on SPE2DX25FVJFC.
Is contract SPE2DX25FVJFC an order under another contract?
Yes. SPE2DX25FVJFC is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVJFC competed?
The extent of competition for SPE2DX25FVJFC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award